Publication | Closed Access

Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?

MedicineSystemic TreatmentClinical TrialsEvidence SayClinical DermatologyDermatologyFirst-line Biologic TreatmentPsoriatic ArthritisModerate-to-severe Psoriasis